World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
28333
World Ranking
12714
National Ranking
1196

Kimme L. Hyrich publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kimme L. Hyrich sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 671 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kimme L. Hyrich D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kimme L. Hyrich sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kimme L. Hyrich is affiliated with the University of Manchester in the United Kingdom and has a focused research profile in the field of medicine, particularly within rheumatology.

Their research covers several main fields and subfields including:

  • Medicine
  • Rheumatology
  • Hematology
  • Immunology
  • Infectious Diseases
  • Speech and Hearing

Key topics addressed in their work involve:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Adolescent and Pediatric Healthcare
  • Chronic Lymphocytic Leukemia Research
  • COVID-19 Clinical Research Studies
  • Biosimilars and Bioanalytical Methods

Kimme L. Hyrich has an extensive publication record in multiple venues, with notable frequent venues including:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Rheumatology Advances in Practice
  • Arthritis & Rheumatology
  • The Lancet Rheumatology

Selected recent papers authored by Kimme L. Hyrich show the breadth of research focus and include:

  • "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update" (2022), published in Annals of the Rheumatic Diseases
  • "Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry" (2020), published in Annals of the Rheumatic Diseases
  • "Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry" (2021), published in Annals of the Rheumatic Diseases
  • "EULAR definition of difficult-to-treat rheumatoid arthritis" (2020), published in Annals of the Rheumatic Diseases
  • "Juvenile idiopathic arthritis" (2022), published in Nature Reviews Disease Primers

The scientist collaborates regularly with several frequent co-authors, including:

  • Lianne Kearsley-Fleet
  • Anne Barton
  • Anja Strangfeld
  • Saskia Lawson-Tovey
  • Pedro Machado

Best Publications

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Milena Gianfrancesco;Kimme L Hyrich;Sarah Al-Adely;Loreto Carmona

  • Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

    W. G. Dixon;K. Watson;M. Lunt;K. L. Hyrich

  • Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

    Kimme L. Hyrich;Kath D. Watson;Alan J. Silman;Deborah P. M. Symmons

  • Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

    W. G. Dixon;K. L. Hyrich;K. D. Watson;M. Lunt

  • Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

    James B. Galloway;Kimme L. Hyrich;Louise K. Mercer;William G. Dixon

  • Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

    W. G. Dixon;K. D. Watson;M. Lunt;K. L. Hyrich

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

    Kimme L. Hyrich;Mark Lunt;Kath D. Watson;Deborah P. M. Symmons

  • EULAR definition of difficult-to-treat rheumatoid arthritis

    György Nagy;Nadia Mt Roodenrijs;Paco Mj Welsing;Melinda Kedves

  • Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

    W. G. Dixon;D. P. M. Symmons;M. Lunt;K. D. Watson

  • Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

    C Potter;K L Hyrich;A Tracey;M Lunt

  • Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

    Mark J Harrison;William G Dixon;Kath D Watson;Yvonne King

  • Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

    W G G Dixon;K L L Hyrich;K D D Watson;M Lunt

  • Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

    W G Dixon;K D Watson;M Lunt;L K Mercer

  • BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

    Tina Ding;Jo Ledingham;Raashid Luqmani;Sarah Westlake

  • Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

    Rebeccah J Mathews;James I Robinson;James I Robinson;Michele Battellino;Chi Wong;Chi Wong

  • A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

    Jeffrey R. Curtis;Archana Jain;Johan Askling;S. Louis Bridges

  • Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

    Suzanne M M Verstappen;Yvonne King;Kath D Watson;Deborah P M Symmons

  • Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

    Elena Nikiphorou;Helga Radner;Katerina Chatzidionysiou;Katerina Chatzidionysiou;Carole Desthieux

  • Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register.

    Amr A Saad;Darren M Ashcroft;Kath D Watson;Kimme L Hyrich

Frequent Co-Authors

Deborah P. M. Symmons
Deborah P. M. Symmons University of Manchester
Mark Lunt
Mark Lunt University of Manchester
Wendy Thomson
Wendy Thomson University of Manchester
Anne Barton
Anne Barton University of Manchester
John D. Isaacs
John D. Isaacs Newcastle University
Ann W. Morgan
Ann W. Morgan University of Leeds
Lucy R. Wedderburn
Lucy R. Wedderburn University College London
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Johan Askling
Johan Askling Karolinska Institute
Ian N. Bruce
Ian N. Bruce University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medicine, various online degrees offer flexible and affordable entry points. Nursing remains a popular pathway. If you’re a registered nurse looking to advance your credentials affordably, explore the cheapest online rn to bsn programs for options that fit your budget.

Individuals with a non-nursing background can transition into advanced nursing roles through direct entry msn programs for non-nurses online, which are designed for those seeking faster routes to a Master’s in Nursing.

If you’re just starting out and seeking accessible programs, consider nursing schools with high acceptance rates. These schools often provide more flexible admission criteria, making them a practical choice for many aspiring nurses.

For those interested in the administrative side of healthcare, check out medical billing and coding online schools that accept financial aid. This field offers remote and entry-level opportunities without the need for extensive clinical training.

Best Scientists Citing Kimme L. Hyrich

Trending Scientists

Recently Published Articles